Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024-2029

Description

Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth

The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development.

According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040, which will fuel demand for tissue diagnostics. This increase highlights how urgently improved diagnostic tools are needed. The complexity of tissue diagnostics expanded due to advancements in cancer treatment, which require enhanced technology and capabilities in laboratories across the globe. Improving local diagnostic capacity is vital for managing the projected growth in cancer incidence worldwide, as it can improve test turnaround times and diagnostic accuracy-both of which substantially impact cancer treatment outcomes.

The pre-analytical staining market in the tissue diagnostics industry is being propelled by several key factors, such as growing advancements in staining technologies, pre-analytical platforms to simplify next-generation sequencing, automated staining platforms, and high-throughput systems to drive efficiency and reproducibility. Tissue diagnostics players are increasingly focusing on developing innovative and advanced systems and stains that enhance the specificity and sensitivity of tissue diagnostics. The advanced staining segment is the second leading segment due to a surge in adoption, especially driven by increased demand for ISH and IHC offerings, regulatory mandates to include CDx as part of pathology tests, and increased partnerships between biopharma companies and diagnostic companies.

Asia-Pacific's growing cancer diagnostics infrastructure, increasing cancer prevalence rate, rising healthcare spending, increasing access to advanced diagnostic technologies, and growing government support all contribute to the region being the fastest-growing market.

Product Code: PFLA-55

Transformation in Global Tissue Diagnostics Industry

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Global Tissue Diagnostic Industry

Growth Environment-Ecosystem in Tissue Diagnostics Industry

Scope of Analysis
Segmentation

Growth Environment-Companies to Action

Competitive Environment
Key Competitor by Technology

Growth Opportunity Analysis-Growth Generator in Tissue Diagnostics Industry

Growth Metrics
Growth Drivers
Growth Restraints
Trends in the Tissue Diagnostics Industry
Forecast Methodology and Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Technology
Primary Growth Opportunities-Tissue Diagnostics Segments
Revenue Forecast by Region
Revenue Forecast Analysis by Region-NA
Tissue Diagnostics Market Dynamics-NA
Revenue Forecast Analysis by Region-Europe
Tissue Diagnostics Market Dynamics-Europe
Revenue Forecast Analysis by Region-APAC
Tissue Diagnostics Market Dynamics-APAC
Revenue Forecast Analysis by Region-MENASA & Latin America
Revenue Forecast by End User
Revenue Forecast Analysis by End User
Revenue Share
Revenue Share Analysis
Competitor Matrix
Global Tissue Diagnostics Market-Notable Activities
Tissue Diagnostics Opportunity and Innovations Roadmap

Growth Opportunity Analysis-Growth Generator in Pre-Analytical Staining

Growth Metrics-Pre-Analytical Staining
Pre-analytical Staining Revenue Forecast
Pre-analytical Staining Revenue Forecast Analysis
Pre-analytical Staining Revenue Forecast Analysis

Growth Opportunity Analysis-Growth Generator in Advanced Staining

Growth Metrics-Advance Staining
Advanced Staining Revenue Forecast
Advanced Staining-Revenue Forecast Analysis
List of FDA-approved Tissue-based CDx, 2022-2023

Growth Opportunity Analysis-Growth Generator in ICP-APLIS

Growth Metrics-ICP-APLIS
ICP-APLIS Revenue Forecast
ICP-APLIS-Revenue Forecast Analysis
ICP-APLIS-Revenue Forecast Analysis

Growth Opportunity Universe in Access Control Solutions

Growth Opportunity 1-Comprehensive Diagnostic Panels for Early Identification Of Cancer Biomarkers
Growth Opportunity 2-Multiomics Analysis for Precision Diagnostics
Growth Opportunity 3-Digital Pathology Capabilities for Tissue-based Companion Diagnostics

Best Practices Recognition

Best Practices Recognition

Frost Radar

Frost Radar

Next Steps

Benefits and Impacts of Growth Opportunities
Next Steps
List of Exhibits
Legal Disclaimer